Physician profile
Makepeace Charles
NPI 1083817142
$3,199.86
in general payments reported to CMS, 2019-2025
10 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $65.94 · 2021: $565 · 2022: $53.34 · 2023: $488 · 2024: $1,535 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,733 · Travel and Lodging: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,733.04 |
| Travel and Lodging | $652.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,441.27 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Nobel Biocare USA | $383.75 | 2019-2023 | Nobelactive |
| Neoss, INC. | $373.03 | 2021-2024 | Neoss Implant System |
| Stryker Corporation | $263.16 | 2023-2024 | Na, Smartlock, Colorado |
| Zimmer Biomet Holdings, INC. | $214.20 | 2020-2021 | |
| Straumann USA LLC | $159.49 | 2023-2024 | |
| C2dx, INC | $151.07 | 2023 | |
| Zimvie INC. | $95.14 | 2022-2025 | |
| Kls-Martin L.P. | $89.07 | 2020-2024 | |
| Acera Surgical, INC. | $29.68 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Makepeace Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.